The G-quadruplex ligand, SYUIQ-FM05, targets proto-oncogene c-kit transcription and induces apoptosis in K562 cells

References

• Al-Obeidi FA, Lam KS. (2000). Development of inhibitors for protein tyrosine kinases. Oncogene, 19, 5690–5701.
   PubMed Web of Science ®Google Scholar
• Beppu K, Jaboine J, Merchant MS, Mackall CL, Thiele CJ. (2004). Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression. J Natl Cancer Inst, 96, 46–55.
   PubMed Web of Science ®Google Scholar
• Bierer DE, Dubenko LG, Zhang P, Lu Q, Imbach PA, Garofalo AW, Phuan PW, Fort DM, Litvak J, Gerber RE, Sloan B, Luo J, Cooper R, Reaven GM. (1998). Antihyperglycemic activities of cryptolepine analogues: An ethnobotanical lead structure isolated from Cryptolepis sanguinolenta. J Med Chem, 41, 2754–2764.
   PubMed Web of Science ®Google Scholar
• Chu S, Holtz M, Gupta M, Bhatia R. (2004). BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells. Blood, 103, 3167–3174.
   PubMed Web of Science ®Google Scholar
• Crews CM, Alessandrini A, Erikson RL. (1992). The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science, 258, 478–480.
   PubMed Web of Science ®Google Scholar
• Dolci S, Pellegrini M, Di Agostino S, Geremia R, Rossi P. (2001). Signaling through extracellular signal-regulated kinase is required for spermatogonial proliferative response to stem cell factor. J Biol Chem, 276, 40225–40233.
   PubMed Web of Science ®Google Scholar
• Domen J, Weissman IL. (2000). Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other. J Exp Med, 192, 1707–1718.
   PubMed Web of Science ®Google Scholar
• Fernando H, Reszka AP, Huppert J, Ladame S, Rankin S, Venkitaraman AR, Neidle S, Balasubramanian S. (2006). A conserved quadruplex motif located in a transcription activation site of the human c-kit oncogene. Biochemistry, 45, 7854–7860.
   PubMed Web of Science ®Google Scholar
• Ferrari S, Grande A, Zucchini P, Manfredini R, Tagliafico E, Rossi E, Temperani P, Torelli G, Emilia G, Torelli U. (1993). Overexpression of c-kit in a leukemic cell population carrying a trisomy 4 and its relationship with the proliferative capacity. Leuk Lymphoma, 9, 495–501.
   PubMed Web of Science ®Google Scholar
• Frost MJ, Ferrao PT, Hughes TP, Ashman LK. (2002). Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant. Mol Cancer Ther, 1, 1115–1124.
   PubMed Web of Science ®Google Scholar
• Gounder MM, Maki RG. (2011). Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor. Cancer Chemother Pharmacol, 67, 25–43.
   PubMed Web of Science ®Google Scholar
• Harada H, Quearry B, Ruiz-Vela A, Korsmeyer SJ. (2004). Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. Proc Natl Acad Sci USA, 101, 15313–15317.
   PubMed Web of Science ®Google Scholar
• Holt SJ, Petrow V. (1947). Cabarzole, carbolines, and related compounds [Part 1. Quindoline Derivatives]. J Chem Soc, 18, 607–611.
   Google Scholar
• Jalal Hosseinimehr S, Inanami O, Hamasu T, Takahashi M, Kashiwakura I, Asanuma T, Kuwabara M. (2004). Activation of c-kit by stem cell factor induces radioresistance to apoptosis through ERK-dependent expression of survivin in HL60 cells. J Radiat Res, 45, 557–561.
   PubMed Web of Science ®Google Scholar
• Kee D, Zalcberg JR. (2012). Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors. Ther Adv Med Oncol, 4, 255–270.
   PubMed Web of Science ®Google Scholar
• Krystal GW, Honsawek S, Litz J, Buchdunger E. (2000). The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth. Clin Cancer Res, 6, 3319–3326.
   PubMed Web of Science ®Google Scholar
• Lasater EA, Bessler WK, Mead LE, Horn WE, Clapp DW, Conway SJ, Ingram DA, Li F. (2008). Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway. Hum Mol Genet, 17, 2336–2344.
   PubMed Web of Science ®Google Scholar
• Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R. (2005). Normal and oncogenic forms of the receptor tyrosine kinase kit. Stem Cells, 23, 16–43.
   PubMed Web of Science ®Google Scholar
• Lu YJ, Ou TM, Tan JH, Hou JQ, Shao WY, Peng D, Sun N, Wang XD, Wu WB, Bu XZ, Huang ZS, Ma DL, Wong KY, Gu LQ. (2008). 5-N-Methylated quindoline derivatives as telomeric g-quadruplex stabilizing ligands: effects of 5-N positive charge on quadruplex binding affinity and cell proliferation. J Med Chem, 51, 6381–6392.
   PubMed Web of Science ®Google Scholar
• Lunghi P, Tabilio A, Dall’Aglio PP, Ridolo E, Carlo-Stella C, Pelicci PG, Bonati A. (2003). Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts. Leukemia, 17, 1783–1793.
   PubMed Web of Science ®Google Scholar
• Orelio C, Dzierzak E. (2007). Bcl-2 expression and apoptosis in the regulation of hematopoietic stem cells. Leuk Lymphoma, 48, 16–24.
   PubMed Web of Science ®Google Scholar
• Ou TM, Lu YJ, Zhang C, Huang ZS, Wang XD, Tan JH, Chen Y, Ma DL, Wong KY, Tang JC, Chan AS, Gu LQ. (2007). Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives. J Med Chem, 50, 1465–1474.
   PubMed Web of Science ®Google Scholar
• Sambol EB, Ambrosini G, Geha RC, Kennealey PT, Decarolis P, O’connor R, Wu YV, Motwani M, Chen JH, Schwartz GK, Singer S. (2006). Flavopiridol targets c-KIT transcription and induces apoptosis in gastrointestinal stromal tumor cells. Cancer Res, 66, 5858–5866.
   PubMed Web of Science ®Google Scholar
• Scholl C, Gilliland DG, Fröhling S. (2008). Deregulation of signaling pathways in acute myeloid leukemia. Semin Oncol, 35, 336–345.
   PubMed Web of Science ®Google Scholar
• Todd AK, Haider SM, Parkinson GN, Neidle S. (2007). Sequence occurrence and structural uniqueness of a G-quadruplex in the human c-kit promoter. Nucleic Acids Res, 35, 5799–5808.
   PubMed Web of Science ®Google Scholar
• Wang WL, Healy ME, Sattler M, Verma S, Lin J, Maulik G, Stiles CD, Griffin JD, Johnson BE, Salgia R. (2000). Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571. Oncogene, 19, 3521–3528.
   PubMed Web of Science ®Google Scholar
• Wang XD, Ou TM, Lu YJ, Li Z, Xu Z, Xi C, Tan JH, Huang SL, An LK, Li D, Gu LQ, Huang ZS. (2010). Turning off transcription of the bcl-2 gene by stabilizing the bcl-2 promoter quadruplex with quindoline derivatives. J Med Chem, 53, 4390–4398.
   PubMed Web of Science ®Google Scholar
• Wang YY, Zhou GB, Yin T, Chen B, Shi JY, Liang WX, Jin XL, You JH, Yang G, Shen ZX, Chen J, Xiong SM, Chen GQ, Xu F, Liu YW, Chen Z, Chen SJ. (2005). AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad Sci USA, 102, 1104–1109.
   PubMed Web of Science ®Google Scholar
• Yang SW, Abdel-Kader M, Malone S, Werkhoven MC, Wisse JH, Bursuker I, Neddermann K, Fairchild C, Raventos-Suarez C, Menendez AT, Lane K, Kingston DG. (1999). Synthesis and biological evaluation of analogues of cryptolepine, an alkaloid isolated from the Suriname rainforest. J Nat Prod, 62, 976–983.
   PubMed Web of Science ®Google Scholar
• Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A. (1987). Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J, 6, 3341–3351.
   PubMed Web of Science ®Google Scholar
• Yu C, Rahmani M, Almenara J, Subler M, Krystal G, Conrad D, Varticovski L, Dent P, Grant S. (2003). Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells. Cancer Res, 63, 2118–2126.
   PubMed Web of Science ®Google Scholar